Accord Biopharma Inc.
4 products tracked · names used in filings: Accord Biopharma Inc.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 15 May 2026🇺🇸 FDA approval
FDA approves biosimilar Immgolis (golimumab-sldi)
Accord Biopharma Inc.; BLA761452; Biosimilar; injection · source
Thu 07 May 2026🇺🇸 FDA approval
FDA approves biosimilar Ennumo (pegfilgrastim-pccg)
Accord Biopharma Inc.; BLA761147; Biosimilar; injectable · source
Thu 15 Jan 2026🇺🇸 FDA approval
FDA approves biosimilar Filkri (filgrastim-laha)
Accord Biopharma Inc.; BLA761027; Biosimilar; injectable · source
Wed 29 Oct 2025🇺🇸 FDA approval
FDA approves biosimilar Osvyrti (denosumab-desu)
Accord Biopharma Inc.; BLA761424; Biosimilar; injectable · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Immgolis golimumab-sldi | Approved | 2026-05-15 |
| 🇺🇸 | Ennumo pegfilgrastim-pccg | Approved | 2026-05-07 |
| 🇺🇸 | Filkri filgrastim-laha | Approved | 2026-01-15 |
| 🇺🇸 | Osvyrti denosumab-desu | Approved | 2025-10-29 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.